Structure and chromosomal localization of the human anti-Müllerian hormone type II receptor gene by Visser, J.A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/21201
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Vol. 215, No. 3, 1995 
October 24, 1995
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Pages 1029-1036
STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN ANTI-
• »
MULLERIAN HORMONE TYPE II RECEPTOR GENE
Jenny A. Visser’, Anke McLuskey, Tessa van Beers, Daniël Okie Weghuis*, Ad
Geurts van Kessel*, J. Anton Grootegoed, and Axel P.N. Themmen
Department of Endocrinology and Reproduction, Faculty of Medicine and Health Sciences,
Erasmus University Rotterdam, Rotterdam, The Netherlands
'"Department of Human Genetics, University Hospital Nijmegen, The Netherlands
Received September 1,1995
SUMMARY: Using the rat anti-miillerian hormone type II receptor (AMHRII) cDNA as a 
probe, two overlapping lambda phage clones containing the AMHRII gene were isolated 
from a human genomic library. Sequence analysis of the exons was performed and the 
exon/intron boundaries were determined. The coding region was found to consist of 11 
exons, divided over 8 kb. The genomic structure resembles that of the related activin type 
II receptor gene. The AMHRII gene was mapped to human chromosome 12q 12-q 13. The 
results reported are essential for identification of AMHRII gene alterations in patients with 
persistent mullerian duct syndrome. e> 199s Academic prom-., me.
Anti-miillerian hormone (AMI-1) is a member the TGFB family of growth and
differentiation factors (1). AMH plays a critical role during male fetal sex differentiation, 
by inducing regression o f  the mullerian ducts, the anlagen of the female urogenital tract 
(2-4). During fetal life, AMH is produced only by the testicular Sertoli cells, but 
postnatally this factor is also found in ovarian granulosa cells (5).
Previous studies have shown that members of the TGF[3 family exert their action via 
a heteromeric signalling complex that includes a type I and a type II receptor (6). Both
I r no areceptors are transmembrane serine/threonine kinases. The 
smaller subfamily, that is characterized by a specific cysteine spacing in the extracellular 
domain and a GS-rich juxtamembrane motif (7).
Corresponding Author. FAX: +31-10-4366832.
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cloned, as new members of the serine/threonine kinase receptor family. AMHRII mRNA is 
expressed in the mesenchymal cells surrounding the miillerian ducts, during the period of 
fetal development that the miillerian ducts respond to AMH (8). Furthermore, COS cells 
transfected with AMHRII cDNA are able to bind AMH (9). AMHRII mRNA was also 
found in fetal gonads, and in Sertoli cells and granulosa cells of adult rats, although the 
function of AMH in the gonads remains to be established (10,11).
Failure of AMH action leads to the Persistent Mullerian Duct Syndrome (PMDS), a 
rare form of male pseudohermaphroditism characterized by the presence of uterus and 
fallopian tubes in otherwise normally virilized males (12). In some cases, this phenotype is 
caused by a mutation in the AMH gene (13). However, the presence of bioactive AMH in 
other PMDS patients (14) indicates resistance of the miillerian ducts to AMH, possibly as a 
result of alterations in the AMHRII gene. A mutation in the AMHRII gene that may result 
in alternative splicing has recently been reported (15).
Herein, we present the genomic structure of the human AMHRII gene and its
chromosomal localization.
MATERIALS AND METHODS
Library screening: Approximately 1.7 x 10fi plaques of a phage lambda EMBL3 human 
CMLO (chronic myeloid leukaemia cell line) genomic DNA library were transferred in 
duplicate to Hybond-N+ nylon filters (Amersham International pic, Little Chalfont, UK), 
and screened with the full length 1.9 kb rat AMHRII cDNA as a probe (8). The probe was 
labelled with [32PJ-dATP (Amersham) by random-priming. Hybridization was done o/n at 
42 C in 50% formamide, 5xSCC, 5x Denhardt’s, 1% SDS, 50 mM Na^HPO./NaH^PO, 
(pH6.8) and 100 jjg/ml denatured herring sperm DNA. The filters were washed in 2x SCC 
and 0,1% SDS at 42 C for 10 minutes prior to autoradiography.
Positive phage lambda clones: Four positive clones were identified on initial screening of 
the genomic library. These clones were purified to homogeneity by secondary and tertiary
screening using the rat AMHRII cDNA probe. Phage DNA of 2 positive clones was
isolated, digested with several restriction enzymes and analyzed by gel electrophoresis to 
orient the genomic DNA with respect to the lambda arms. The DNA was transferred to 
Hybond-N+ filters (Amersham) and probed with fragments of the rat AMHRII cDNA to 
determine the positions of the 5’ and 3’ ends of the gene, the overlap, and the coding 
regions. Fragments of the coding regions were subcloned into the appropriate sites of the 
vector pBluescript KS(+) (Stratagene, La Jolla, CA, U.S.A.) for sequence analysis.
DNA sequence analysis: DNA sequencing was performed on plasmid DNA by the
dideoxy chain termination method, using M13 and human AMHRII primers. Sequence
alignments were performed using the sequence analysis program DNAMAN (Lynnon 
Biosoft, Vaudrieul, Quebec, Canada) and Clustal V.
In situ hybridization to metaphase chromosomes: Phage DNA was labelled with biotin- 
14-dATP using the bio-NICK system (Life Technologies, Gaithersburg, MD, U.S.A.). The 
labelled DNA was precipitated with ethanol in the presence of herring sperm DNA. 
Precipitated DNA was dissolved and denatured at 80 C for 10 min followed by incubation
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for 30 min at 37 C, and added to heat-denatured chromosome spreads where hybridization 
was carried out o/n in a moist chamber at 37 C. After posthybridization washing (50% 
formamide, 2 x SSC, at 42 C) and blocking with nonfat dry milk powder, the hybridized 
probe was detected using avidin-FITC (Vector Laboratories, Burlingame, CA, U.S.A.) with 
two amplification steps using rabbit-anti-FITC (Dako, Glostrup, Denmark) and mouse-anti- 
rabbit FITC (Jackson Immunoresearch, West Grove, U.S.A.). Chromosome spreads were 
mounted in antifade solution with blue dye DAPI.
RESULTS AND DISCUSSION
Isolation and characterization of the human AMHRII gene
A human CMLO genomic library was screened with the rat AMHRII cDNA as a probe. 
Four positive clones were identified and two of these clones were used to construct a 
restriction enzyme map of the human AMHRII gene. Restriction enzyme mapping, 
Southern blot analysis using specific regions of the rat AMHRII cDNA as a probe, and 
DNA sequencing revealed that the AMHRII gene consists of 11 exons and 10 introns, and 
spans approximately 8 kb (Figure 1).
All eleven exons of the human AMHRII gene, and the intron/exon boundaries were 
sequenced. The DNA and protein sequences of the deduced open reading frame and the 
DNA sequences of the intron-exon boundaries are shown in Figure 2. Exons 2-10 vary in 
length from 78 bp to 234 bp, and the coding regions of the first (exon 1) and last (exon 
11) exons are 49 bp and 297 bp, respectively. These lengths are consistent with the 
observation that the length of coding exons usually does not exceed 300 bp (16). Introns 4 
and 10 are relatively long, 3 kb and 1 kb, respectively, and contribute to approximately 
half of the gene. The other introns are much shorter, varying from 120 bp to 425 bp. All 
of the introns start with GT and end with AG, consistent with the donor/acceptor splice 
rule (17).
Clone 3.1
S K H K H H E H E S
I k
Clone 7.1
S H K H K H H E H S
1 kb 1 2 3-180
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7 0910  11
Figure 1. Structure of the human AMHRII gene. The overlapping phage lambda clones 3.1 
and 7.1 are shown with the unique restriction enzymes that were used to construct a linear 
map. The relative length and localization of the exons (boxes) and introns is shown 
underneath (drawn to scale). E: EcoRl; H: Hindlll; K: Kpnl; S: Sail. The Sail sites are 
contained in the lambda EMBL3 arms and do not occur in the human AMHRII gene.
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Figure 2. A Nucleotide and amino acid sequence of the deduced open reading frame. The 
arrowheads indicate the beginning (>) and end (<) of the respective exon. B Intron/exon 
boundaries in the human AMHRII gene. The nucleotide sequence for each intron/exon 
boundary and the size of each exon and intron are shown. The consensus acceptor/donor 
sequences are shown in bold.
Comparison of the deduced human AMHRII amino acid sequence to the sequences 
of the rat and rabbit receptors, revealed well-conserved sequences with few amino acid 
changes (Figure 3). The amino acid identity is approximately 80 %. In the AMH receptor
the Sei US in the sequence HRDLS is conserved in the mammalian species
investigated (Figure 3; see also (18)). This feature distinguishes the AMH type II receptor 
from the other members of the TGF(3 receptor family, which contain a lysine residue at 
that position. Another conspicuous characteristic of the AMHRII is the cysteine spacing in 
the extracellular ligand binding domain, which may reflect the evolutionary distance of the 
AMH-AMHRII pair to the other ligand-serine/threonine kinase receptor pairs.
Similar to the activin type II receptor (ActRII) (19) and the bone morphogenetic
protein 2/4 type I receptor (BMPRI) (20) gene, an gene contains 11
exons. However, the AMHRII gene is remarkably small: 8 kb compared to >60 kb for the
ActRII gene and 38.2 kb for the BMPRI gene. The exons
functional domains in the AMHRII protein molecule. The signal sequence is encoded by 
exon 1, the extracellular ligand binding domain by exons 2 and 3, and the transmembrane
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Figure 3. Comparison o f the human (hAMHRII), the rabbit (ocAMHRII) and the rat 
(rAMHRII) AMHRII amino acid sequences. Reversed script is used to highlight amino 
acid residues that are found at the same position in at least two of the three receptors.
domain is encoded by exon 4. The remaining exons 5-11 contain the sequence information 
for the kinase domain. When the gene structure of the receptors of the TGF(3 family is 
compared, the spacing of the exons and even the division of the functional protein domains
into numbers of exons indicates that the receptors show evolutionary
relationship. Thus, this comparison provides no information on similarities in mechanism 
of action of the different serine/threonine kinase receptors.
Chromosomal localization of the AMHRII gene
Fluorescent in situ hybridization to metaphase chromosomes using the two isolated lambda 
phages, showed fluorescent signals at 12ql2-13 (Figure 4). One of the clones (clone 3.1) 
also showed a signal at 9q, but this was not observed with clone 7.1 (not shown). Other 
genes in the 12qJ2/13 region 
(Wntl), the Keratin 3 gene
Wingless-type MMTV 1
 (Krt3), the retinoic acid receptor-y gene (Rarg) and 
Homeobox C cluster genes (Hoxc) (21). In the mouse, we mapped the mouse AMHRII
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Figure 4. Chromosomal localization of the human AMHRII gene. The photomicrograph 
shows localization of the AMHRII probe on 12ql2-ql3 using fluorescence in situ 
hybridization (left panel). The identification of individual chromosomes was deduced from 
converted DAPI banding patterns (right panel). The hybridization sites are marked by 
arrows.
gene to chromosome 15F (result not shown). This region (15F(50-58)) is syntenic with the 
human chromosome 12, and contains mouse homologues of the genes mentioned above
(22).
In conclusion, we have cloned and sequenced the human gene encoding the AMHRII.
The AMHRII is well conserved between mammalian species. This information is essential 
to identify possible gene alterations in diseases involving the miillerian ducts.
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